Point-of-Care Diagnostics Market Insights and Projection to 2034

Market Size in 2025	Market Forecast in 2034	CAGR (in %)	Base Year
USD 42,180 Million	USD 98,640 Million	9.9%	2025

Table Of Content

Point-of-Care Diagnostics Market — Detailed Table of Contents

Chapter 1: Introduction

1.1 Report Scope and Market Definition

1.1.1 Point-of-Care Diagnostics — Definition and Scope

1.1.2 Inclusions and Exclusions

1.1.3 Key Assumptions

1.2 Research Objectives

1.3 Market Stakeholders and Target Audience

1.4 Abbreviations and Acronyms

Chapter 2: Research Methodology

2.1 Research Approach Overview

2.2 Primary Research

2.2.1 Stakeholders Consulted

2.2.2 Primary Data Collection Process

2.3 Secondary Research

2.3.1 Secondary Sources Reviewed

2.3.2 Data Extraction and Validation

2.4 Market Sizing and Forecast Methodology

2.4.1 Bottom-Up Approach

2.4.2 Top-Down Approach

2.4.3 Data Triangulation and Quality Assurance

2.5 Report Limitations and Disclaimers

Chapter 3: Executive Summary

3.1 Global Point-of-Care Diagnostics Market Snapshot

3.2 Key Market Highlights

3.3 Dominant Segments at a Glance

3.4 Regional Snapshot

3.5 Competitive Summary

Chapter 4: Market Dynamics

4.1 Market Drivers

4.1.1 Rising Global Chronic & Infectious Disease Burden

4.1.2 Regulatory Acceleration — CLIA-Waived Molecular Testing

4.1.3 Decentralisation of Healthcare Infrastructure

4.1.4 AI Integration & Multiplex Platform Capability

4.2 Market Restraints

4.2.1 Regulatory Complexity & Device Recall Risk

4.2.2 Reimbursement Constraints & Payer Policy Tightening

4.2.3 Supply-Chain Cost Inflation & Tariff Disruption

4.3 Market Opportunities

4.3.1 Emerging Market Rural Diagnostic Infrastructure

4.3.2 Companion Diagnostics Co-Development

4.3.3 AI-Enabled Remote Patient Monitoring Integration

4.3.4 STI & Oncology Point-of-Care Expansion

4.4 Market Challenges

4.4.1 EHR Integration & Data Interoperability

4.4.2 Quality Assurance in Decentralised Settings

4.4.3 Workforce Training for Non-Laboratory Operators

Chapter 5: Point-of-Care Diagnostics — By Product

5.1 Overview and Product Segment Comparison

5.2 Glucose Testing — Market Sizing, Drivers, Forecast

5.3 Infectious Disease Testing — Market Sizing, Drivers, Forecast

5.4 Cardiac Markers — Market Sizing, Drivers, Forecast

5.5 Coagulation Testing — Market Sizing, Drivers, Forecast

5.6 HbA1c Testing — Market Sizing, Drivers, Forecast

5.7 Pregnancy & Fertility Testing — Market Sizing, Drivers, Forecast

5.8 Drug-of-Abuse Testing — Market Sizing, Drivers, Forecast

5.9 Others — Market Sizing, Drivers, Forecast

Chapter 6: Point-of-Care Diagnostics — By Technology

6.1 Overview and Technology Comparison

6.2 Lateral Flow Assays — Market Sizing, Drivers, Forecast

6.3 Molecular Diagnostics — Market Sizing, Drivers, Forecast

6.4 Immunoassay Analyzers — Market Sizing, Drivers, Forecast

6.5 Biochemistry — Market Sizing, Drivers, Forecast

Chapter 7: Point-of-Care Diagnostics — By Mode of Purchase

7.1 Overview and Mode Comparison

7.2 Prescription-Based Testing Products — Market Sizing, Forecast

7.3 Over-the-Counter (OTC) Testing Products — Market Sizing, Forecast

Chapter 8: Point-of-Care Diagnostics — By End User

8.1 Overview and End-User Comparison

8.2 Hospitals — Market Sizing, Drivers, Forecast

8.3 Clinics — Market Sizing, Drivers, Forecast

8.4 Home Settings — Market Sizing, Drivers, Forecast

8.5 Diagnostic Centres — Market Sizing, Drivers, Forecast

8.6 Ambulatory Care Centres — Market Sizing, Drivers, Forecast

Chapter 9: Regional Analysis

9.1 Global POC Diagnostics Market — Regional Overview

9.2 North America POC Diagnostics Market

9.2.1 North America Market Overview

9.2.2 The U.S. POC Diagnostics Market

9.2.3 Canada POC Diagnostics Market

9.2.4 Mexico POC Diagnostics Market

9.3 Europe POC Diagnostics Market

9.3.1 Europe Market Overview

9.4 Asia Pacific POC Diagnostics Market

9.4.1 Asia Pacific Market Overview

9.5 Latin America POC Diagnostics Market

9.5.1 Latin America Market Overview

9.6 The Middle East POC Diagnostics Market

9.6.1 The Middle East Market Overview

9.6.2 GCC (Saudi Arabia, UAE, Qatar, Kuwait, Bahrain, Oman)

9.6.3 Israel | 9.6.4 Turkey | 9.6.5 Iran | 9.6.6 Rest of The Middle East

9.7 Africa POC Diagnostics Market

9.7.1 Africa Market Overview

Chapter 10: Competitive Landscape

10.1 Market Concentration and Fragmentation Analysis

10.2 Competitive Positioning Map

10.3 Key Strategies Adopted by Market Leaders

10.4 Mergers, Acquisitions, and Strategic Partnerships

10.5 New Product Launches and Regulatory Approvals

Chapter 11: Company Profiles

11.1 Abbott Laboratories — Overview | POC Products | Revenue & Share | Recent Developments

11.2 F. Hoffmann-La Roche Ltd. — Overview | POC Products | Revenue & Share | Recent Developments

11.3 Siemens Healthineers AG — Overview | POC Products | Revenue & Share | Recent Developments

11.4 Danaher Corporation (Cepheid) — Overview | POC Products | Revenue & Share | Recent Developments

11.5 QuidelOrtho Corporation — Overview | POC Products | Revenue & Share | Recent Developments

11.6 BD (Becton, Dickinson and Company) — Overview | POC Products | Recent Developments

11.7 Thermo Fisher Scientific Inc. — Overview | POC Products | Recent Developments

11.8 bioMérieux SA — Overview | POC Products | Recent Developments

11.9 QIAGEN N.V. — Overview | POC Products | Recent Developments

11.10 Bio-Rad Laboratories Inc. — Overview | POC Products | Recent Developments

11.11 EKF Diagnostics Holdings plc — Overview | POC Products | Recent Developments

11.12 Trinity Biotech plc — Overview | POC Products | Recent Developments

11.13 Sysmex Corporation — Overview | POC Products | Recent Developments

11.14 Nova Biomedical — Overview | POC Products | Recent Developments

11.15 Werfen — Overview | POC Products | Recent Developments

Chapter 12: Recent Developments and Strategic Moves

12.1 Mergers and Acquisitions

12.2 Product Launches and Regulatory Approvals

12.3 Strategic Partnerships and Collaborations

12.4 Investments and Capacity Expansions

12.5 Regulatory & Policy Changes (FDA, EMA, WHO, NMPA)

Chapter 13: Future Outlook and Forecast Summary

13.1 Point-of-Care Diagnostics Market Size Forecast, 2026–2034

13.2 Segment Forecast Summary (Product, Technology, End User)

13.3 Regional Forecast Summary

13.4 Scenario Analysis (Conservative, Base Case, Optimistic)

13.5 Key Success Factors and Strategic Recommendations

Chapter 14: Appendix

14.1 Research Methodology Detail

14.2 List of Primary Research Participants (Anonymised)

14.3 Data Sources

14.4 Glossary of Terms

14.5 About Zion Market Research

List of Tables (Selected)

Table 1: Global POC Diagnostics Market Size, USD Mn, 2019–2034

Table 2: Global POC Diagnostics Market by Product, USD Mn, 2019–2034

Table 3: Global POC Diagnostics Market by Technology, USD Mn, 2019–2034

Table 4: Global POC Diagnostics Market by Mode of Purchase, USD Mn, 2019–2034

Table 5: Global POC Diagnostics Market by End User, USD Mn, 2019–2034

Table 6: North America POC Diagnostics Market by Country, USD Mn, 2019–2034

Table 7: Europe POC Diagnostics Market by Country, USD Mn, 2019–2034

Table 8: Asia Pacific POC Diagnostics Market by Country, USD Mn, 2019–2034

Table 9: Latin America POC Diagnostics Market by Country, USD Mn, 2019–2034

Table 10: The Middle East POC Diagnostics Market by Country, USD Mn, 2019–2034

Table 11: Africa POC Diagnostics Market by Country, USD Mn, 2019–2034

Table 12: Glucose Testing Market Size, Global, USD Mn, 2019–2034

Table 13: Infectious Disease Testing Market Size, Global, USD Mn, 2019–2034

Table 14: Cardiac Markers POC Market Size, Global, USD Mn, 2019–2034

Table 15: Company Revenue & Market Share Benchmarking, 2025

Table 16: Competitive Strategy Matrix — Top 15 Players

Table 17: Recent M&A and Strategic Developments, 2024–2025

Table 18: POC Diagnostics Regulatory Clearances, 2024–2025

Table 19: Country POC Diagnostics Reimbursement Framework Summary

Table 20: Market Size Scenario Analysis (Conservative / Base / Optimistic)

List of Figures (Selected)

Figure 1: Global POC Diagnostics Market Size & Growth, 2019–2034

Figure 2: Market Share by Product Sub-segment, 2025

Figure 3: Market Share by Technology, 2025

Figure 4: Market Share by End User, 2025

Figure 5: Regional Revenue Share, 2025

Figure 6: Asia Pacific Market Growth Trajectory, 2025–2034

Figure 7: DROC Analysis Framework

Figure 8: Value Chain & Ecosystem Map

Figure 9: Competitive Positioning Map

Figure 10: POC Diagnostics Technology Evolution Timeline

Methodology

FrequentlyAsked Questions

What does the Zion Market Research's Point-of-Care Diagnostics report include?

The Zion Market Research's Global Point-of-Care Diagnostics Market report comprises 300+ pages covering: full market sizing and forecasting for 2019–2034 across five segmentation dimensions (product, technology, mode of purchase, end user, and region); 110 data tables and 80 figures; 15 company profiles with competitive strategy analysis; country-level forecasts for 35+ geographies across all six Zion Market Research regions; full DROC analysis (drivers, restraints, opportunities, challenges); research methodology documentation; and recent developments table covering 2024–2025 strategic events. The report is delivered in PDF format with immediate digital download.

What is the Point-of-Care Diagnostics market size and forecast?

According to Zion Market Research, the Global Point-of-Care Diagnostics market was valued at USD 42,180 Mn in 2025 and is projected to reach USD 98,640 Mn by 2034, expanding at a CAGR of 9.9% during the forecast period 2026–2034. Historical data covers 2019–2025. North America leads with approximately 42% revenue share; Asia Pacific is the fastest-growing region at approximately 10.7% CAGR. Infectious disease testing is the dominant product segment.

How is the Point-of-Care Diagnostics market segmented in this report?

The report segments the market across five dimensions: (1) By Product — glucose testing, infectious disease testing, cardiac markers, coagulation testing, HbA1c testing, pregnancy & fertility testing, drug-of-abuse testing, and others; (2) By Technology — lateral flow assays, molecular diagnostics, immunoassay analyzers, and biochemistry; (3) By Mode of Purchase — prescription-based and over-the-counter; (4) By End User — hospitals, clinics, home settings, diagnostic centres, and ambulatory care centres; (5) By Region — six ZMR regions covering 35+ countries.

Which countries are covered in this report?

The report provides country-level analysis across 35+ geographies. North America: The U.S., Canada, Mexico. Europe: Germany, France, U.K., Italy, Spain, Russia, BENELUX, Sweden, Denmark, Poland, Austria, Rest of Europe. Asia Pacific: China, Japan, India, South Korea, Australia, Thailand, Indonesia, Vietnam, Malaysia, Philippines, Taiwan, Rest of Asia Pacific. Latin America: Brazil, Argentina, Colombia, Chile, Peru, Rest of Latin America. The Middle East: GCC (Saudi Arabia, UAE, Qatar, Kuwait, Bahrain, Oman), Israel, Turkey, Iran, Rest of Middle East. Africa: South Africa, Egypt, Nigeria, Algeria, Morocco, Rest of Africa. The Middle East and Africa are always covered as separate regions — never combined.

What customization options are available?

Zion Market Research offers 10% free customization with every report purchase — allowing buyers to specify additional segments, specific country breakdowns, or adjusted forecast scenarios at no extra cost. Beyond 10%, paid customization is available including: extended forecast periods (post-2034); additional country-level deep-dives not included in the standard scope; competitor-specific analysis; and primary research add-ons including executive interviews with specific stakeholder types. Contact sales@zionmarketresearch.com or call +1 (302) 444-0166 to discuss your specific customisation requirements.

How can I access or purchase the Point-of-Care Diagnostics report?

Three options are available: (1) Free Sample: Access sample chapters, key data tables, and the condensed TOC (2) Full Report: Purchase the complete 300+ page PDF (3) Custom Research Inquiry: Contact the ZMR team directly at sales@zionmarketresearch.com | +1 (302) 444-0166 | Toll Free: +1 (855) 465-4651 to discuss multi-user licensing, enterprise access, or custom scope requirements.